<!doctype html public "-//IETF//DTD HTML//EN">
<HTML>
<HEAD>
<TITLE>United States Securities and Exchange Commission EDGAR Filing</TITLE>
<META NAME="date" CONTENT="04/04/2008">
</HEAD>
<BODY style="line-height:12pt; font-family:Times New Roman; font-size:10pt; color:#000000">
<P style="margin:0px" align=center>As filed with the Securities and Exchange Commission on April&nbsp;7, 2008 Registration No.&nbsp;333-______.</P>
<P style="margin-top:0px; margin-bottom:2.2px; padding-bottom:4px; border-bottom:4px solid #000000" align=right>&nbsp;</P>
<P style="margin:0px; padding-top:4px; border-top:1.333px solid #000000" align=right>&nbsp;</P>
<P style="margin:0px" align=center><B>SECURITIES AND EXCHANGE COMMISSION</B></P>
<P style="margin:0px" align=center><B>Washington, D.C. 20549</B></P>
<P style="margin-top:13.333px; margin-bottom:13.333px" align=center>&#151;&#151;&#151;&#151;&#151;&#151;&#151;</P>
<P style="margin:0px" align=center><B>FORM S-8</B></P>
<P style="margin:0px" align=center><B>REGISTRATION STATEMENT</B></P>
<P style="margin:0px" align=center><B>UNDER</B></P>
<P style="margin:0px" align=center><B>THE SECURITIES ACT OF 1933</B></P>
<P style="margin-top:13.333px; margin-bottom:13.333px" align=center>&#151;&#151;&#151;&#151;&#151;&#151;&#151;</P>
<P style="margin:0px" align=center><B>PHARMANET DEVELOPMENT GROUP, INC.</B></P>
<P style="line-height:10pt; margin:0px; font-size:8pt" align=center><I>(Exact name of registrant as specified in its charter)</I></P>
<P style="margin:0px"><BR></P>
<TABLE style="font-size:10pt" cellspacing=0 align=center><TR height=0 style="font-size:0"><TD width=312></TD><TD width=312></TD></TR>
<TR><TD valign=top width=312><P style="margin:0px" align=center><B>Delaware</B></P>
</TD><TD valign=top width=312><P style="margin:0px" align=center><B>59-2407464</B></P>
</TD></TR>
<TR><TD valign=top width=312><P style="line-height:10pt; margin:0px; font-size:8pt" align=center><I>(State or other jurisdiction of<BR>
 incorporation or organization)</I></P>
</TD><TD valign=top width=312><P style="line-height:10pt; margin:0px; font-size:8pt" align=center><I>(I.R.S. Employer <BR>
Identification No.)</I></P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<P style="margin:0px" align=center><B>504 Carnegie Center, Princeton, New Jersey 08540</B></P>
<P style="line-height:10pt; margin-top:0px; margin-bottom:5.333px; font-size:8pt" align=center><I>(Address of Principal Executive Offices)</I></P>
<P style="margin:0px" align=center>&#151;&#151;&#151;&#151;&#151;&#151;&#151;</P>
<P style="margin:0px" align=center><B>2004 Employee Stock Purchase Plan, as amended and restated</B></P>
<P style="line-height:10pt; margin-top:0px; margin-bottom:5.333px; font-size:8pt" align=center><I>(Full title of the plan)</I></P>
<P style="margin-top:0px; margin-bottom:6.667px" align=center>&#151;&#151;&#151;&#151;&#151;&#151;&#151;</P>
<P style="margin:0px" align=center><B>Mr.&nbsp;John P. Hamill<BR>
PharmaNet Development Group, Inc.<BR>
504 Carnegie Center</B></P>
<P style="margin:0px" align=center><B>Princeton, New Jersey 08540</B></P>
<P style="margin:0px" align=center><B>(609) 951-6800</B></P>
<P style="line-height:10pt; margin-top:0px; margin-bottom:5.333px; font-size:8pt" align=center><I>(Name, address, including zip code, and telephone number, including area code, of agent for service)</I></P>
<P style="margin-top:0px; margin-bottom:6.667px" align=center>&#151;&#151;&#151;&#151;&#151;&#151;&#151;</P>
<P style="margin:0px" align=center><B><I>Copies of all communications, including all communications sent to the agent for service, should be sent to:</I></B></P>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px" align=center><B>Emilio Ragosa, Esq.</B></P>
<P style="margin:0px" align=center><B>Morgan Lewis &amp; Bockius, LLP</B></P>
<P style="margin:0px" align=center><B>502 Carnegie Center</B></P>
<P style="margin:0px" align=center><B>Princeton, New Jersey 08540</B></P>
<P style="margin-top:0px; margin-bottom:6.667px" align=center><B>(609) 919-6600</B></P>
<P style="margin:0px">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definitions of &#147;large accelerated filer&#148;, &#147;accelerated filer&#148;, and &#147;smaller reporting company&#148; in Rule&nbsp;12b-2 of the Exchange Act: </P>
<P style="margin:0px"><BR></P>
<TABLE style="font-size:10pt" cellspacing=0 align=center><TR height=0 style="font-size:0"><TD width=148.933></TD><TD width=10.067></TD><TD width=113.8></TD><TD width=10></TD><TD width=152.867></TD><TD width=10></TD><TD width=178.333></TD></TR>
<TR><TD valign=top width=148.933><P style="margin:0px">Large accelerated filer&nbsp;<FONT style="font-family:Wingdings">o</FONT> </P>
</TD><TD valign=top width=10.067><P style="margin:0px">&nbsp;</P>
</TD><TD valign=top width=113.8><P style="margin:0px">Accelerated filer&nbsp;<FONT style="font-family:Wingdings">&#254;</FONT> </P>
</TD><TD valign=top width=10><P style="margin:0px">&nbsp;</P>
</TD><TD valign=top width=152.867><P style="margin:0px">Non-accelerated filer&nbsp;<FONT style="font-family:Wingdings">o</FONT> </P>
</TD><TD valign=top width=10><P style="margin:0px">&nbsp;</P>
</TD><TD valign=top width=178.333><P style="margin:0px">Smaller reporting company&nbsp;<FONT style="font-family:Wingdings">o</FONT></P>
</TD></TR>
<TR><TD valign=top width=148.933><P style="margin:0px">&nbsp;</P>
</TD><TD valign=top width=10.067><P style="margin:0px">&nbsp;&nbsp;&nbsp;</P>
</TD><TD valign=top width=113.8><P style="margin:0px">&nbsp;</P>
</TD><TD valign=top width=10><P style="margin:0px">&nbsp;&nbsp;&nbsp;</P>
</TD><TD valign=top width=152.867><P style="margin:0px">(Do not check if a smaller <BR>
reporting company)</P>
</TD><TD valign=top width=10><P style="margin:0px">&nbsp;&nbsp;&nbsp;</P>
</TD><TD valign=top width=178.333><P>&nbsp;</P></TD></TR>
</TABLE>
<P style="margin-top:0px; margin-bottom:2.2px; padding-bottom:4px; border-bottom:1.333px solid #000000">&nbsp;</P>
<P style="margin:0px; padding-top:4px; border-top:4px solid #000000">&nbsp;</P>
<P style="margin:13.333px" align=center><BR></P>
<P style="margin:13.333px" align=center><BR>
<BR></P>
<HR style="margin-top:9.6px; margin-bottom:9.6px" noshade size=1.333>
<P style="margin-top:13.333px; margin-bottom:13.333px; page-break-before:always" align=center><B>CALCULATION OF REGISTRATION FEE</B></P>
<TABLE style="font-size:10pt" cellspacing=0 align=center><TR height=0 style="font-size:0"><TD width=125.267></TD><TD width=125.267></TD><TD width=125.333></TD><TD width=125.533></TD><TD width=125.667></TD></TR>
<TR><TD style="border-left:3px double #000000; border-top:3px double #000000; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=bottom width=125.267><P style="line-height:10pt; margin-top:0px; margin-bottom:1.133px; padding-left:4px; padding-right:4px" align=center><B>Title of securities to be registered</B></P>
</TD><TD style="border-top:3px double #000000; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=bottom width=125.267><P style="line-height:10pt; margin-top:0px; margin-bottom:1.133px; padding-left:4px; padding-right:4px" align=center><B>Amount to be registered (2)</B></P>
</TD><TD style="border-top:3px double #000000; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=bottom width=125.333><P style="line-height:10pt; margin-top:0px; margin-bottom:1.133px; padding-left:4px; padding-right:4px" align=center><B>Proposed maximum offering price per share (3)</B></P>
</TD><TD style="border-top:3px double #000000; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=bottom width=125.533><P style="line-height:10pt; margin-top:0px; margin-bottom:1.133px; padding-left:4px; padding-right:4px" align=center><B>Proposed maximum aggregate offering price (4)</B></P>
</TD><TD style="border-top:3px double #000000; border-right:3px double #000000; border-bottom:1px solid #000000" valign=bottom width=125.667><P style="line-height:10pt; margin-top:0px; margin-bottom:1.133px; padding-left:4px; padding-right:4px" align=center><B>Amount of registration fee</B></P>
</TD></TR>
<TR><TD style="border-left:3px double #000000; border-right:1px solid #000000; border-bottom:3px double #000000" valign=bottom width=125.267><P style="margin:0px; padding-left:12px; padding-right:4px; text-indent:-8px">Common Stock, including Preferred Stock Purchase Rights (1)</P>
</TD><TD style="border-right:1px solid #000000; border-bottom:3px double #000000" valign=bottom width=125.267><P style="line-height:14pt; margin-top:0px; margin-bottom:1.133px; padding-left:4px; padding-right:4px" align=center>400,000</P>
</TD><TD style="border-right:1px solid #000000; border-bottom:3px double #000000" valign=bottom width=125.333><P style="line-height:14pt; margin-top:0px; margin-bottom:1.133px; padding-left:4px; padding-right:4px" align=center>$24.92</P>
</TD><TD style="border-right:1px solid #000000; border-bottom:3px double #000000" valign=bottom width=125.533><P style="line-height:14pt; margin-top:0px; margin-bottom:1.133px; padding-left:4px; padding-right:4px" align=center>$9,968,000</P>
</TD><TD style="border-right:3px double #000000; border-bottom:3px double #000000" valign=bottom width=125.667><P style="line-height:14pt; margin-top:0px; margin-bottom:1.133px; padding-left:4px; padding-right:4px" align=center>$391.75</P>
</TD></TR>
</TABLE>
<P style="margin-top:0px; margin-bottom:6.667px">&#151;&#151;&#151;&#151;&#151;&#151;&#151;</P>
<P style="margin-top:0px; margin-bottom:-16px; padding-left:32px; text-indent:-32px">(1) </P>
<P style="margin-top:0px; margin-bottom:6.667px; padding-left:32px">Prior to the occurrence of certain events, the Preferred Stock Purchase Rights will not be evidenced separately from the Common Stock.</P>
<P style="margin-top:0px; margin-bottom:-16px; padding-left:32px; text-indent:-32px">(2)</P>
<P style="margin-top:0px; margin-bottom:6.667px; padding-left:32px">On each of June&nbsp;21, 2005, August&nbsp;24, 2006, and June&nbsp;6, 2007, an additional 100,000, 200,000 and 100,000 shares, respectively, of common stock became available for issuance under the PharmaNet Development Group, Inc. 2004 Employee Stock Purchase Plan, as amended and restated, in accordance with the provisions of the plan. As a result, this registration statement covers such additional 400,000 shares of common stock, for an aggregate of 550,000 shares of common stock registered under such plan.</P>
<P style="margin-top:0px; margin-bottom:-16px; padding-left:32px; text-indent:-32px">(3)</P>
<P style="margin-top:0px; margin-bottom:6.667px; padding-left:32px">Pursuant to Rule&nbsp;416 of the Securities Act of 1933, as amended, this registration statement shall also cover any additional shares of common stock which become issuable under the PharmaNet Development Group, Inc. 2004 Employee Stock Purchase Plan, as amended and restated, by reason of any merger, consolidation, reorganization, recapitalization, reincorporation, stock dividend, dividend in property other than cash, stock split, liquidating dividend, combination of shares, exchange of shares, change in corporate structure or other transaction not involving the receipt of consideration by PharmaNet Development Group, Inc., which results in an increase in the number of the outstanding shares of common stock of PharmaNet Development Group, Inc. </P>
<P style="margin-top:0px; margin-bottom:-16px; padding-left:32px; text-indent:-32px">(4)</P>
<P style="margin-top:0px; margin-bottom:6.667px; padding-left:32px">Estimated solely for the purposes of calculating the registration fee pursuant to Rules 457(c) and 457(h) of the Securities Act of 1933, as amended, and based upon the average of the reported high and low sales prices per share of the common stock of PharmaNet Development Group, Inc., on April&nbsp;3, 2008, as reported by the NASDAQ Global Select Market. </P>
<P style="margin-top:0px; margin-bottom:13.333px" align=center><BR>
<BR></P>
<HR style="margin-top:9.6px; margin-bottom:9.6px" noshade size=1.333>
<P style="margin-top:0px; margin-bottom:13.333px; page-break-before:always" align=center><B>PART I - INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS</B></P>
<P style="margin-top:0px; margin-bottom:-16px"><B>Item 1.</B></P>
<P style="margin-top:0px; margin-bottom:13.333px; text-indent:60px"><B>Plan Information</B></P>
<P style="margin-top:0px; margin-bottom:13.333px">We will send or give the documents containing the information specified in Part I of Form&nbsp;S-8 to employees as specified by the Securities and Exchange Commission Rule&nbsp;428(b)(1) under the Securities Act of 1933. We do not need to file these documents with the Securities and Exchange Commission either as part of this registration statement or as prospectuses or prospectus supplements under Rule&nbsp;424 of the Securities Act.</P>
<P style="margin-top:0px; margin-bottom:-16px"><B>Item 2.</B></P>
<P style="margin-top:0px; margin-bottom:13.333px; text-indent:60px"><B>Registrant Information and Employee Plan Annual Information</B></P>
<P style="margin-top:0px; margin-bottom:13.333px">We will furnish without charge to each person to whom the prospectus is delivered, upon the oral or written request of such person, a copy of any and all of the documents incorporated by reference (other than exhibits to such documents). Requests should be directed to the attention of Ms.&nbsp;Anne-Marie Hess, PharmaNet Development Group, Inc., 504 Carnegie Center, Princeton, New Jersey 08540.</P>
<P style="margin-top:0px; margin-bottom:13.333px" align=center><BR></P>
<P style="margin-top:0px; margin-bottom:13.333px" align=center><BR>
<BR></P>
<HR style="margin-top:9.6px; margin-bottom:9.6px" noshade size=1.333>
<P style="margin-top:0px; margin-bottom:13.333px; page-break-before:always" align=center><B>PART II - INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</B></P>
<P style="margin-top:0px; margin-bottom:-16px"><B>Item 3.</B></P>
<P style="margin-top:0px; margin-bottom:13.333px; text-indent:60px"><B>Incorporation of Documents by Reference</B></P>
<P style="margin-top:0px; margin-bottom:13.333px">PharmaNet Development Group, Inc. (the &#147;Registrant&#148;) hereby incorporates by reference into this Registration Statement the following documents previously filed with the Securities and Exchange Commission (the &#147;Commission&#148;):</P>
<P style="margin-top:0px; margin-bottom:-16px; padding-left:72px; text-indent:-24px">(a)</P>
<P style="margin-top:0px; margin-bottom:13.333px; padding-left:72px">The Registrant&#146;s Annual Report on Form&nbsp;10-K for the fiscal year ended December&nbsp;31, 2007 (Commission File No.&nbsp;001-161119), filed on March&nbsp;31, 2008, pursuant to Section&nbsp;13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;), in which there is set forth the audited financial statements for the Registrant&#146;s fiscal year ended December&nbsp;31, 2007; </P>
<P style="margin-top:0px; margin-bottom:-16px; padding-left:72px; text-indent:-24px">(b)</P>
<P style="margin-top:0px; margin-bottom:13.333px; padding-left:72px">The Registrant&#146;s Current Report on Form&nbsp;8-K filed on March&nbsp;10, 2008;</P>
<P style="margin-top:0px; margin-bottom:-16px; padding-left:72px; text-indent:-24px">(c)</P>
<P style="margin-top:0px; margin-bottom:13.333px; padding-left:72px">The description of the Registrant&#146;s capital stock contained in its registration statement on Form&nbsp;8-A filed with the SEC on December&nbsp;28, 2005 to register Series&nbsp;A Junior Participating Preferred Stock Purchase Rights under the Exchange Act, including any amendments or reports filed for the purpose of updating such description; and</P>
<P style="margin-top:0px; margin-bottom:-16px; padding-left:72px; text-indent:-24px">(d)</P>
<P style="margin-top:0px; margin-bottom:13.333px; padding-left:72px">The description of the Registrant&#146;s capital stock contained in its registration statement on Form&nbsp;8-A filed with the SEC on June&nbsp;15, 2001 to register its common stock under the Exchange Act, including any amendments or reports filed for the purpose of updating such description.</P>
<P style="margin-top:0px; margin-bottom:13.333px">All reports and definitive proxy or information statements filed pursuant to Section&nbsp;13(a), 13(c), 14 or 15(d) of the Exchange Act after the date of this Registration Statement and prior to the filing of a post-effective amendment which indicates that all securities offered hereby have been sold or which de-registers all securities then remaining unsold shall be deemed to be incorporated by reference into this Registration Statement and to be a part hereof from the date of filing of such documents. Unless expressly incorporated into this Registration Statement, a report furnished on Form&nbsp;8-K under the Exchange Act shall not be incorporated by reference into this Registration Statement. Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any subsequently filed document which also is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.</P>
<P style="margin-top:0px; margin-bottom:-16px"><B>Item 4.</B></P>
<P style="margin-top:0px; margin-bottom:13.333px; text-indent:60px"><B>Description of Securities.</B></P>
<P style="margin-top:0px; margin-bottom:13.333px">Not Applicable.</P>
<P style="margin-top:0px; margin-bottom:-16px"><B>Item 5.</B></P>
<P style="margin-top:0px; margin-bottom:13.333px; text-indent:60px"><B>Interests of Named Experts and Counsel.</B></P>
<P style="margin-top:0px; margin-bottom:13.333px">Not Applicable.</P>
<P style="margin-top:0px; margin-bottom:-16px"><B>Item 6.</B></P>
<P style="margin-top:0px; margin-bottom:13.333px; text-indent:60px"><B>Indemnification of Directors and Officers.</B></P>
<P style="margin-top:0px; margin-bottom:13.333px">Our certificate of incorporation, as amended, provides that we shall indemnify our officers and directors, employees and agents and former officers, directors, employees and agents against expenses (including attorney&#146;s fees), judgments, fines and amounts paid in settlement arising out of his or her services on behalf of us subject to the qualifications contained in Delaware law as it now exists. We also cannot indemnify our officers and directors when we assert a direct claim against them. We have entered into indemnification agreements with our officers and directors providing for indemnification and containing an advancement of expenses provision. Delaware law generally provides that a corporation shall have such power to indemnify such persons to the extent they acted in good faith in a manner they reasonably believed to be in, or not opposed to, the best interests of the corporation and, with respect to any criminal action or proceeding, had no reasonable cause to believe the conduct was unlawful. In </P>
<P style="margin-top:0px; margin-bottom:13.333px"><BR>
<BR></P>
<P style="margin:0px" align=center>II-1</P>
<P style="margin:0px" align=justify><BR></P>
<HR style="margin-top:9.6px; margin-bottom:9.6px" noshade size=1.333>
<P style="margin-top:0px; margin-bottom:13.333px; page-break-before:always">the event any such person shall be judged liable, such indemnification shall apply only if approved by the court in which the action was brought. Any other indemnification shall be made by a majority vote of the board of directors (excluding any directors who were party to such action), or by a committee of directors designated by majority vote of the board of directors or by independent legal counsel in a written opinion, or by a majority vote of stockholders (excluding any stockholders who were parties to such action).</P>
<P style="margin-top:0px; margin-bottom:13.333px">Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers or persons controlling PharmaNet Development Group, Inc., pursuant to the foregoing provisions, we have been informed that in the opinion of the Securities and Exchange Commission, such indemnification is against public policy as expressed in the Act and is therefore unenforceable.</P>
<P style="margin-top:0px; margin-bottom:-16px"><B>Item 7.</B></P>
<P style="margin-top:0px; margin-bottom:13.333px; text-indent:60px"><B>Exemption from Registration Claimed.</B></P>
<P style="margin-top:0px; margin-bottom:13.333px">Not Applicable.</P>
<P style="margin-top:0px; margin-bottom:-16px"><B>Item 8.</B></P>
<P style="margin-top:0px; margin-bottom:13.333px; text-indent:60px"><B>Exhibits.</B></P>
<TABLE style="font-size:10pt" cellspacing=0 align=center><TR height=0 style="font-size:0"><TD width=88.667></TD><TD width=17.067></TD><TD width=518.267></TD></TR>
<TR><TD style="border-bottom:1px solid #000000" valign=top width=88.667><P style="line-height:10pt; margin:0px; font-size:8pt" align=justify><B>Exhibit&nbsp;Number</B></P>
</TD><TD valign=top width=17.067><P style="margin:0px; font-size:8pt" align=justify><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></P>
</TD><TD style="border-bottom:1px solid #000000" valign=top width=518.267><P style="line-height:10pt; margin:0px; font-size:8pt" align=justify><B>Item</B></P>
</TD></TR>
<TR><TD valign=top width=88.667><P style="margin-top:6.667px; margin-bottom:0px; color:#0000FF" align=center><A HREF="exhbit51.htm"><U>5.1</U></A><FONT style="color:#000000"></FONT></P>
</TD><TD valign=top width=17.067><P>&nbsp;</P></TD><TD valign=top width=518.267><P style="margin-top:6.667px; margin-bottom:0px" align=justify>Legal Opinion of Morgan, Lewis &amp; Bockius LLP (filed herewith)</P>
</TD></TR>
<TR><TD valign=top width=88.667><P style="margin-top:6.667px; margin-bottom:0px; color:#0000FF" align=center><A HREF="exhibit231.htm"><U>23.1</U></A><FONT style="color:#000000"></FONT></P>
</TD><TD valign=top width=17.067><P>&nbsp;</P></TD><TD valign=top width=518.267><P style="margin-top:6.667px; margin-bottom:0px" align=justify>Consent of Grant Thornton, LLP (filed herewith)</P>
</TD></TR>
<TR><TD valign=top width=88.667><P style="margin-top:6.667px; margin-bottom:0px; color:#0000FF" align=center><A HREF="exhbit51.htm"><U>23.2</U></A><FONT style="color:#000000"></FONT></P>
</TD><TD valign=top width=17.067><P>&nbsp;</P></TD><TD valign=top width=518.267><P style="margin-top:6.667px; margin-bottom:0px" align=justify>Consent of Morgan, Lewis &amp; Bockius LLP<SUP>(1)</SUP> (filed herewith)</P>
</TD></TR>
<TR><TD valign=top width=88.667><P style="margin-top:6.667px; margin-bottom:0px; color:#0000FF" align=center><A HREF="#poa"><U>24.1</U></A><FONT style="color:#000000"></FONT></P>
</TD><TD valign=top width=17.067><P>&nbsp;</P></TD><TD valign=top width=518.267><P style="margin-top:6.667px; margin-bottom:0px" align=justify>Power of Attorney (included on signature page)</P>
</TD></TR>
<TR><TD valign=top width=88.667><P style="margin-top:6.667px; margin-bottom:0px" align=center>99.1</P>
</TD><TD valign=top width=17.067><P>&nbsp;</P></TD><TD valign=top width=518.267><P style="margin-top:6.667px; margin-bottom:0px" align=justify>2004 Employee Stock Purchase Plan, as amended and restated <SUP>(2)</SUP></P>
</TD></TR>
</TABLE>
<P style="margin:0px">&#151;&#151;&#151;&#151;&#151;&#151;&#151;</P>
<P style="margin-top:0px; margin-bottom:-16px; padding-left:32px; text-indent:-32px">(1)</P>
<P style="margin-top:0px; margin-bottom:6.667px; padding-left:32px">Contained in the legal opinion.</P>
<P style="margin-top:0px; margin-bottom:-16px; padding-left:32px; text-indent:-32px">(2) </P>
<P style="margin-top:0px; margin-bottom:6.667px; padding-left:32px">Filed as an exhibit to the Company&#146;s annual report on Form&nbsp;10-K which was filed on March&nbsp;31, 2008.</P>
<P style="margin-top:8.867px; margin-bottom:-16px"><B>Item 9.</B></P>
<P style="margin-top:0px; margin-bottom:13.333px; text-indent:60px"><B>Undertakings</B></P>
<P style="margin-top:0px; margin-bottom:-16px; padding-left:48px" align=justify>A.</P>
<P style="margin-top:0px; margin-bottom:13.333px; padding-left:48px; text-indent:24px" align=justify>The undersigned Registrant hereby undertakes:</P>
<P style="margin-top:0px; margin-bottom:-16px; padding-left:48px; text-indent:48px" align=justify>(i)</P>
<P style="margin-top:0px; margin-bottom:13.333px; padding-left:48px; text-indent:96px" align=justify>To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:</P>
<P style="margin-top:0px; margin-bottom:-16px; padding-left:48px; text-indent:96px" align=justify>(a)</P>
<P style="margin-top:0px; margin-bottom:13.333px; padding-left:48px; text-indent:144px" align=justify>To include any prospectus required by Section&nbsp;10(a)(3) of the Securities Act;</P>
<P style="margin-top:0px; margin-bottom:-16px; padding-left:48px; text-indent:96px" align=justify>(b)</P>
<P style="margin-top:0px; margin-bottom:13.333px; padding-left:48px; text-indent:144px" align=justify>To reflect in the prospectus any facts or events arising after the effective date of this Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in this Registration Statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule&nbsp;424(b) if, in the aggregate, the changes in volume and price represent no more than 20&nbsp;percent change in the maximum aggregate offering price set forth in the &#147;Calculation of Registration Fee&#148; table in the effective registration statement; and</P>
<P style="margin-top:0px; margin-bottom:-16px; padding-left:48px; text-indent:96px" align=justify>(c)</P>
<P style="margin-top:0px; margin-bottom:13.333px; padding-left:48px; text-indent:144px" align=justify>To include any material information with respect to the plan of distribution not previously disclosed in this Registration Statement or any material change to such information in this Registration Statement;</P>
<P style="margin-top:0px; margin-bottom:13.333px; padding-left:48px; text-indent:96px" align=justify><I>provided, however,</I> that paragraphs (i) and (ii) of this section do not apply if the Registration Statement is on Form&nbsp;S-8 and the information required to be included in a post-effective </P>
<P style="margin-top:0px; margin-bottom:13.333px" align=justify><BR>
<BR></P>
<P style="margin:0px" align=center>II-2</P>
<P style="margin:0px" align=justify><BR></P>
<HR style="margin-top:9.6px; margin-bottom:9.6px" noshade size=1.333>
<P style="margin-top:0px; margin-bottom:13.333px; padding-left:48px; page-break-before:always" align=justify>amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the Registrant pursuant to Section&nbsp;13 or Section&nbsp;15(d) of the Exchange Act that are incorporated by reference in this Registration Statement.</P>
<P style="margin-top:6.667px; margin-bottom:-16px; padding-left:48px; text-indent:48px">(ii)</P>
<P style="margin-top:0px; margin-bottom:6.667px; padding-left:48px; text-indent:96px">That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial <I>bona fide</I> offering thereof.</P>
<P style="margin-top:6.667px; margin-bottom:-16px; padding-left:48px; text-indent:48px">(iii)</P>
<P style="margin-top:0px; margin-bottom:6.667px; padding-left:48px; text-indent:96px">To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.</P>
<P style="margin-top:0px; margin-bottom:-16px; padding-left:48px">B.</P>
<P style="margin-top:0px; margin-bottom:13.333px; padding-left:48px; text-indent:24px">The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Registrant&#146;s annual report pursuant to Section&nbsp;13(a) or Section&nbsp;15(d) of the Exchange Act that is incorporated by reference in this Registration Statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial <I>bona fide</I> offering thereof.</P>
<P style="margin-top:0px; margin-bottom:-16px; padding-left:48px">C.</P>
<P style="margin-top:0px; margin-bottom:13.333px; padding-left:48px; text-indent:24px">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.</P>
<P style="margin-top:0px; margin-bottom:13.333px" align=center><BR>
<BR></P>
<P style="margin:0px" align=center>II-3</P>
<P style="margin:0px" align=justify><BR></P>
<HR style="margin-top:9.6px; margin-bottom:9.6px" noshade size=1.333>
<P style="margin-top:0px; margin-bottom:13.333px; page-break-before:always" align=center><B>SIGNATURES</B></P>
<P style="margin-top:0px; margin-bottom:13.333px">Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form&nbsp;S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Princeton, State of New Jersey, on April&nbsp;7, 2008.</P>
<TABLE style="font-size:10pt" cellspacing=0 align=center><TR height=0 style="font-size:0"><TD width=326.733></TD><TD width=26.6></TD><TD width=270.667></TD></TR>
<TR><TD valign=top width=326.733><P>&nbsp;</P></TD><TD valign=top width=297.267 colspan=2><P style="margin:0px"><B>PHARMANET DEVELOPMENT GROUP,&nbsp;INC.</B></P>
</TD></TR>
<TR><TD valign=top width=326.733><P>&nbsp;</P></TD><TD valign=top width=297.267 colspan=2><P style="margin:0px"><B>&nbsp;</B></P>
</TD></TR>
<TR><TD valign=top width=326.733><P>&nbsp;</P></TD><TD valign=top width=26.6><P style="margin:0px">By:</P>
</TD><TD style="border-bottom:1px solid #000000" valign=top width=270.667><P style="line-height:normal; margin:0px">/s/ J<FONT style="font-size:6pt">EFFREY</FONT> P. M<FONT style="font-size:6pt">C</FONT>M<FONT style="font-size:6pt">ULLEN</FONT></P>
</TD></TR>
<TR><TD valign=top width=326.733><P>&nbsp;</P></TD><TD valign=top width=26.6><P>&nbsp;</P></TD><TD valign=top width=270.667><P style="margin:0px">Jeffrey P. McMullen</P>
</TD></TR>
<TR><TD valign=top width=326.733><P>&nbsp;</P></TD><TD valign=top width=26.6><P>&nbsp;</P></TD><TD valign=top width=270.667><P style="margin:0px">Chief Executive Officer</P>
</TD></TR>
</TABLE>
<P style="margin-top:0px; margin-bottom:13.333px" align=center><BR></P>
<P style="margin-top:0px; margin-bottom:13.333px" align=center><B>POWER OF ATTORNEY<A NAME="poa"></A></B></P>
<P style="margin-top:0px; margin-bottom:13.333px">Each person whose signature appears below hereby constitutes and appoints each of Jeffrey P. McMullen and John P. Hamill, his true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution for him and in his name, place and stead, in any and all capacities, to sign any or all amendments or supplements to this registration statement, whether pre-effective or post-effective, and any registration statement relating hereto or thereto that is filed pursuant to Rule&nbsp;462(b) under the Act, and to file the same with all exhibits thereto and other documents in connection therewith, with the SEC, granting unto said attorneys-in-fact and agents full power and authority to do and perform each and every act and thing necessary or appropriate to be done with respect to this registration statement or any amendments or supplements hereto in the premises, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or their substitute or substitutes, may lawfully do or cause to be done by virtue thereof.</P>
<P style="margin-top:0px; margin-bottom:13.333px">Pursuant to the requirements of the Act, this registration statement has been signed below by the following persons in the capacities indicated.</P>
<TABLE style="font-size:10pt" cellspacing=0 align=center><TR height=0 style="font-size:0"><TD width=159.933></TD><TD width=20></TD><TD width=329.867></TD><TD width=23.333></TD><TD width=90.867></TD></TR>
<TR><TD style="border-bottom:1px solid #000000" valign=bottom width=159.933><P style="line-height:normal; margin:0px; padding-left:6.733px; padding-right:6.733px; text-indent:-6.733px">/s/ P<FONT style="font-size:6pt">ETER</FONT> G. T<FONT style="font-size:6pt">OMBROS</FONT></P>
</TD><TD valign=top width=20><P style="margin:0px" align=justify>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>
</TD><TD valign=bottom width=329.867><P style="line-height:11.3pt; margin:0px">Chairman of the Board of Directors</P>
</TD><TD valign=top width=23.333><P style="margin:0px" align=center>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>
</TD><TD valign=bottom width=90.867><P style="line-height:11.3pt; margin:0px" align=center>April&nbsp;7, 2008</P>
</TD></TR>
<TR><TD valign=bottom width=159.933><P style="line-height:11.3pt; margin:0px; padding-left:6.733px; padding-right:6.733px; text-indent:-6.733px">Peter G. Tombros</P>
</TD><TD valign=top width=20><P>&nbsp;</P></TD><TD valign=bottom width=329.867><P>&nbsp;</P></TD><TD valign=top width=23.333><P>&nbsp;</P></TD><TD valign=bottom width=90.867><P>&nbsp;</P></TD></TR>
<TR><TD valign=top width=159.933><P style="margin:0px">&nbsp;</P>
</TD><TD valign=top width=20><P>&nbsp;</P></TD><TD valign=top width=329.867><P>&nbsp;</P></TD><TD valign=top width=23.333><P>&nbsp;</P></TD><TD valign=top width=90.867><P>&nbsp;</P></TD></TR>
<TR><TD style="border-bottom:1px solid #000000" valign=top width=159.933><P style="line-height:normal; margin:0px; padding-left:6.733px; padding-right:6.733px; text-indent:-6.733px">/s/ J<FONT style="font-size:6pt">EFFREY</FONT> P. M<FONT style="font-size:6pt">C</FONT>M<FONT style="font-size:6pt">ULLEN</FONT></P>
</TD><TD valign=top width=20><P>&nbsp;</P></TD><TD valign=top width=329.867 rowspan=2><P style="line-height:11.3pt; margin:0px">President and Chief Executive Officer and Director <BR>
(Principal Executive Officer)</P>
</TD><TD valign=top width=23.333><P>&nbsp;</P></TD><TD valign=top width=90.867><P style="line-height:11.3pt; margin:0px" align=center>April&nbsp;7, 2008</P>
</TD></TR>
<TR><TD valign=top width=159.933><P style="line-height:11.3pt; margin:0px">Jeffrey P. McMullen</P>
</TD><TD valign=top width=20><P>&nbsp;</P></TD><TD valign=top width=23.333><P>&nbsp;</P></TD><TD valign=top width=90.867><P>&nbsp;</P></TD></TR>
<TR><TD valign=bottom width=159.933><P style="margin:0px; padding-left:6.733px; padding-right:6.733px; text-indent:-6.733px">&nbsp;</P>
</TD><TD valign=top width=20><P>&nbsp;</P></TD><TD valign=bottom width=329.867><P>&nbsp;</P></TD><TD valign=top width=23.333><P>&nbsp;</P></TD><TD valign=bottom width=90.867><P>&nbsp;</P></TD></TR>
<TR><TD style="border-bottom:1px solid #000000" valign=top width=159.933><P style="line-height:normal; margin:0px; padding-left:6.733px; padding-right:6.733px; text-indent:-6.733px">/s/ J<FONT style="font-size:6pt">OHN</FONT> P. H<FONT style="font-size:6pt">AMILL</FONT></P>
</TD><TD valign=top width=20><P>&nbsp;</P></TD><TD valign=top width=329.867 rowspan=2><P style="line-height:11.3pt; margin:0px">Executive Vice President and Chief Financial Officer <BR>
(Principal Financial Officer and Principal Accounting Officer)</P>
</TD><TD valign=top width=23.333><P>&nbsp;</P></TD><TD valign=top width=90.867><P style="line-height:11.3pt; margin:0px" align=center>April&nbsp;7, 2008</P>
</TD></TR>
<TR><TD valign=top width=159.933><P style="line-height:11.3pt; margin:0px">John P. Hamill</P>
</TD><TD valign=top width=20><P>&nbsp;</P></TD><TD valign=top width=23.333><P>&nbsp;</P></TD><TD valign=top width=90.867><P>&nbsp;</P></TD></TR>
<TR><TD valign=bottom width=159.933><P>&nbsp;</P></TD><TD valign=top width=20><P>&nbsp;</P></TD><TD valign=bottom width=329.867><P>&nbsp;</P></TD><TD valign=top width=23.333><P>&nbsp;</P></TD><TD valign=bottom width=90.867><P>&nbsp;</P></TD></TR>
<TR><TD style="border-bottom:1px solid #000000" valign=bottom width=159.933><P style="line-height:normal; margin:0px; padding-left:6.733px; padding-right:6.733px; text-indent:-6.733px">/s/ R<FONT style="font-size:6pt">OLF</FONT> A. C<FONT style="font-size:6pt">LASSON</FONT></P>
</TD><TD valign=top width=20><P>&nbsp;</P></TD><TD valign=bottom width=329.867><P style="line-height:11.3pt; margin:0px">Director</P>
</TD><TD valign=top width=23.333><P>&nbsp;</P></TD><TD valign=bottom width=90.867><P style="line-height:11.3pt; margin:0px" align=center>April&nbsp;7, 2008</P>
</TD></TR>
<TR><TD valign=bottom width=159.933><P style="line-height:11.3pt; margin:0px; padding-left:6.733px; padding-right:6.733px; text-indent:-6.733px">Rolf A. Classon</P>
</TD><TD valign=top width=20><P>&nbsp;</P></TD><TD valign=bottom width=329.867><P>&nbsp;</P></TD><TD valign=top width=23.333><P>&nbsp;</P></TD><TD valign=bottom width=90.867><P>&nbsp;</P></TD></TR>
<TR><TD valign=bottom width=159.933><P style="margin:0px; padding-left:6.733px; padding-right:6.733px; text-indent:-6.733px">&nbsp;</P>
</TD><TD valign=top width=20><P>&nbsp;</P></TD><TD valign=bottom width=329.867><P>&nbsp;</P></TD><TD valign=top width=23.333><P>&nbsp;</P></TD><TD valign=bottom width=90.867><P>&nbsp;</P></TD></TR>
<TR><TD style="border-bottom:1px solid #000000" valign=bottom width=159.933><P style="line-height:normal; margin:0px; padding-left:6.733px; padding-right:6.733px; text-indent:-6.733px">/s/ L<FONT style="font-size:6pt">EWIS</FONT> R. E<FONT style="font-size:6pt">LIAS</FONT>, MD</P>
</TD><TD valign=top width=20><P>&nbsp;</P></TD><TD valign=bottom width=329.867><P style="line-height:11.3pt; margin:0px">Director</P>
</TD><TD valign=top width=23.333><P>&nbsp;</P></TD><TD valign=bottom width=90.867><P style="line-height:11.3pt; margin:0px" align=center>April&nbsp;7, 2008</P>
</TD></TR>
<TR><TD valign=bottom width=159.933><P style="line-height:11.3pt; margin:0px; padding-left:6.733px; padding-right:6.733px; text-indent:-6.733px">Lewis R. Elias, MD</P>
</TD><TD valign=top width=20><P>&nbsp;</P></TD><TD valign=bottom width=329.867><P>&nbsp;</P></TD><TD valign=top width=23.333><P>&nbsp;</P></TD><TD valign=bottom width=90.867><P>&nbsp;</P></TD></TR>
<TR><TD valign=bottom width=159.933><P style="margin:0px; padding-left:6.733px; padding-right:6.733px; text-indent:-6.733px">&nbsp;</P>
</TD><TD valign=top width=20><P>&nbsp;</P></TD><TD valign=bottom width=329.867><P>&nbsp;</P></TD><TD valign=top width=23.333><P>&nbsp;</P></TD><TD valign=bottom width=90.867><P>&nbsp;</P></TD></TR>
<TR><TD style="border-bottom:1px solid #000000" valign=bottom width=159.933><P style="line-height:normal; margin:0px; padding-left:6.733px; padding-right:6.733px; text-indent:-6.733px">/s/ A<FONT style="font-size:6pt">RNOLD</FONT> G<FONT style="font-size:6pt">OLIEB</FONT></P>
</TD><TD valign=top width=20><P>&nbsp;</P></TD><TD valign=bottom width=329.867><P style="line-height:11.3pt; margin:0px">Director</P>
</TD><TD valign=top width=23.333><P>&nbsp;</P></TD><TD valign=bottom width=90.867><P style="line-height:11.3pt; margin:0px" align=center>April&nbsp;7, 2008</P>
</TD></TR>
<TR><TD valign=bottom width=159.933><P style="line-height:11.3pt; margin:0px; padding-left:6.733px; padding-right:6.733px; text-indent:-6.733px">Arnold Golieb</P>
</TD><TD valign=top width=20><P>&nbsp;</P></TD><TD valign=bottom width=329.867><P>&nbsp;</P></TD><TD valign=top width=23.333><P>&nbsp;</P></TD><TD valign=bottom width=90.867><P>&nbsp;</P></TD></TR>
<TR><TD valign=bottom width=159.933><P style="margin:0px; padding-left:6.733px; padding-right:6.733px; text-indent:-6.733px">&nbsp;</P>
</TD><TD valign=top width=20><P>&nbsp;</P></TD><TD valign=bottom width=329.867><P>&nbsp;</P></TD><TD valign=top width=23.333><P>&nbsp;</P></TD><TD valign=bottom width=90.867><P>&nbsp;</P></TD></TR>
<TR><TD style="border-bottom:1px solid #000000" valign=bottom width=159.933><P style="line-height:normal; margin:0px; padding-left:6.733px; padding-right:6.733px; text-indent:-6.733px">/s/ P<FONT style="font-size:6pt">ER</FONT> W<FONT style="font-size:6pt">OLD</FONT>-O<FONT style="font-size:6pt">LSEN</FONT></P>
</TD><TD valign=top width=20><P>&nbsp;</P></TD><TD valign=bottom width=329.867><P style="line-height:11.3pt; margin:0px">Director</P>
</TD><TD valign=top width=23.333><P>&nbsp;</P></TD><TD valign=bottom width=90.867><P style="line-height:11.3pt; margin:0px" align=center>April&nbsp;7, 2008</P>
</TD></TR>
<TR><TD valign=bottom width=159.933><P style="line-height:11.3pt; margin:0px; padding-left:6.733px; padding-right:6.733px; text-indent:-6.733px">Per Wold-Olsen</P>
</TD><TD valign=top width=20><P>&nbsp;</P></TD><TD valign=bottom width=329.867><P>&nbsp;</P></TD><TD valign=top width=23.333><P>&nbsp;</P></TD><TD valign=bottom width=90.867><P>&nbsp;</P></TD></TR>
<TR><TD valign=bottom width=159.933><P style="margin:0px; padding-left:6.733px; padding-right:6.733px; text-indent:-6.733px">&nbsp;</P>
</TD><TD valign=top width=20><P>&nbsp;</P></TD><TD valign=bottom width=329.867><P>&nbsp;</P></TD><TD valign=top width=23.333><P>&nbsp;</P></TD><TD valign=bottom width=90.867><P>&nbsp;</P></TD></TR>
<TR><TD style="border-bottom:1px solid #000000" valign=bottom width=159.933><P style="line-height:normal; margin:0px; padding-left:6.733px; padding-right:6.733px; text-indent:-6.733px">/s/ D<FONT style="font-size:6pt">AVID</FONT> M. O<FONT style="font-size:6pt">LIVER</FONT></P>
</TD><TD valign=top width=20><P>&nbsp;</P></TD><TD valign=bottom width=329.867><P style="line-height:11.3pt; margin:0px">Director</P>
</TD><TD valign=top width=23.333><P>&nbsp;</P></TD><TD valign=bottom width=90.867><P style="line-height:11.3pt; margin:0px" align=center>April&nbsp;7, 2008</P>
</TD></TR>
<TR><TD valign=bottom width=159.933><P style="line-height:11.3pt; margin:0px; padding-left:6.733px; padding-right:6.733px; text-indent:-6.733px">David M. Oliver</P>
</TD><TD valign=top width=20><P>&nbsp;</P></TD><TD valign=bottom width=329.867><P>&nbsp;</P></TD><TD valign=top width=23.333><P>&nbsp;</P></TD><TD valign=bottom width=90.867><P>&nbsp;</P></TD></TR>
</TABLE>
<P style="margin-top:0px; margin-bottom:13.333px" align=center><BR>
<BR></P>
<P style="margin:0px" align=center>II-4</P>
<P style="margin:0px" align=justify><BR></P>
<HR style="margin-top:9.6px; margin-bottom:9.6px" noshade size=1.333>
<P style="margin-top:0px; margin-bottom:13.333px; page-break-before:always" align=center><B>EXHIBIT INDEX</B></P>
<TABLE style="font-size:10pt" cellspacing=0 align=center><TR height=0 style="font-size:0"><TD width=88.667></TD><TD width=17.067></TD><TD width=518.267></TD></TR>
<TR><TD style="border-bottom:1px solid #000000" valign=top width=88.667><P style="line-height:10pt; margin:0px; font-size:8pt" align=justify><B>Exhibit&nbsp;Number</B></P>
</TD><TD valign=top width=17.067><P style="margin:0px; font-size:8pt" align=justify><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></P>
</TD><TD style="border-bottom:1px solid #000000" valign=top width=518.267><P style="line-height:10pt; margin:0px; font-size:8pt" align=justify><B>Item</B></P>
</TD></TR>
<TR><TD valign=top width=88.667><P style="margin-top:6.667px; margin-bottom:0px; color:#0000FF" align=center><A HREF="exhbit51.htm"><U>5.1</U></A><FONT style="color:#000000"></FONT></P>
</TD><TD valign=top width=17.067><P>&nbsp;</P></TD><TD valign=top width=518.267><P style="margin-top:6.667px; margin-bottom:0px" align=justify>Legal Opinion of Morgan, Lewis &amp; Bockius LLP (filed herewith)</P>
</TD></TR>
<TR><TD valign=top width=88.667><P style="margin-top:6.667px; margin-bottom:0px; color:#0000FF" align=center><A HREF="exhibit231.htm"><U>23.1</U></A><FONT style="color:#000000"></FONT></P>
</TD><TD valign=top width=17.067><P>&nbsp;</P></TD><TD valign=top width=518.267><P style="margin-top:6.667px; margin-bottom:0px" align=justify>Consent of Grant Thornton, LLP (filed herewith)</P>
</TD></TR>
<TR><TD valign=top width=88.667><P style="margin-top:6.667px; margin-bottom:0px; color:#0000FF" align=center><A HREF="exhbit51.htm"><U>23.2</U></A><FONT style="color:#000000"></FONT></P>
</TD><TD valign=top width=17.067><P>&nbsp;</P></TD><TD valign=top width=518.267><P style="margin-top:6.667px; margin-bottom:0px" align=justify>Consent of Morgan, Lewis &amp; Bockius LLP<SUP>(1)</SUP> (filed herewith)</P>
</TD></TR>
<TR><TD valign=top width=88.667><P style="margin-top:6.667px; margin-bottom:0px; color:#0000FF" align=center><A HREF="#poa"><U>24.1</U></A><FONT style="color:#000000"></FONT></P>
</TD><TD valign=top width=17.067><P>&nbsp;</P></TD><TD valign=top width=518.267><P style="margin-top:6.667px; margin-bottom:0px" align=justify>Power of Attorney (included on signature page)</P>
</TD></TR>
<TR><TD valign=top width=88.667><P style="margin-top:6.667px; margin-bottom:0px" align=center>99.1</P>
</TD><TD valign=top width=17.067><P>&nbsp;</P></TD><TD valign=top width=518.267><P style="margin-top:6.667px; margin-bottom:0px" align=justify>2004 Employee Stock Purchase Plan, as amended and restated <SUP>(2)</SUP></P>
</TD></TR>
</TABLE>
<P style="margin:0px">&#151;&#151;&#151;&#151;&#151;&#151;&#151;</P>
<P style="margin-top:0px; margin-bottom:-16px; padding-left:32px; text-indent:-32px">(1)</P>
<P style="margin-top:0px; margin-bottom:6.667px; padding-left:32px">Contained in the legal opinion.</P>
<P style="margin-top:0px; margin-bottom:-16px; padding-left:32px; text-indent:-32px">(2) </P>
<P style="margin-top:0px; margin-bottom:6.667px; padding-left:32px">Filed as an exhibit to the Company&#146;s annual report on Form&nbsp;10-K which was filed on March&nbsp;31, 2008.</P>
<P style="margin-top:0px; margin-bottom:13.333px"><BR></P>
<P style="margin-top:0px; margin-bottom:13.333px"><BR>
<BR></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify><BR></P>
</BODY>
<!-- EDGAR Validation Code: BD65B5E5 -->
</HTML>
[{"type": "S-8", "sequence": "1", "filename": "pdgis8.htm", "description": "FORM S-8", "secsgml_size_bytes": 47947}]
{"company-data": {"conformed-name": "PharmaNet Development Group Inc", "cik": "0001089542", "assigned-sic": "8731", "irs-number": "592407464", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-150124", "film-number": "08743683"}, "business-address": {"street1": "504 CARNEGIE CENTER", "city": "PRINCETON", "state": "NJ", "zip": "08540-6242", "phone": "609-951-6800"}, "mail-address": {"street1": "504 CARNEGIE CENTER", "city": "PRINCETON", "state": "NJ", "zip": "08540-6242"}, "former-company": {"former-conformed-name": "SFBC INTERNATIONAL INC", "date-changed": "19990625"}}
United States Securities and Exchange Commission EDGAR Filing
As filed with the Securities and Exchange Commission on April 7, 2008 Registration No. 333-______.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
———————
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
———————
PHARMANET DEVELOPMENT GROUP, INC.
(Exact name of registrant as specified in its charter)
Delaware
59-2407464
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)
504 Carnegie Center, Princeton, New Jersey 08540
(Address of Principal Executive Offices)
———————
2004 Employee Stock Purchase Plan, as amended and restated
(Full title of the plan)
———————
Mr. John P. Hamill
PharmaNet Development Group, Inc.
504 Carnegie Center
Princeton, New Jersey 08540
(609) 951-6800
(Name, address, including zip code, and telephone number, including area code, of agent for service)
———————
Copies of all communications, including all communications sent to the agent for service, should be sent to:
Emilio Ragosa, Esq.
Morgan Lewis & Bockius, LLP
502 Carnegie Center
Princeton, New Jersey 08540
(609) 919-6600
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definitions of "large accelerated filer", "accelerated filer", and "smaller reporting company" in Rule 12b-2 of the Exchange Act:
Large accelerated filer
o
Accelerated filer
þ
Non-accelerated filer
o
Smaller reporting company
o
(Do not check if a smaller
reporting company)
CALCULATION OF REGISTRATION FEE
Title of securities to be registered
Amount to be registered (2)
Proposed maximum offering price per share (3)
Proposed maximum aggregate offering price (4)
Amount of registration fee
Common Stock, including Preferred Stock Purchase Rights (1)
400,000
$24.92
$9,968,000
$391.75
———————
(1)
Prior to the occurrence of certain events, the Preferred Stock Purchase Rights will not be evidenced separately from the Common Stock.
(2)
On each of June 21, 2005, August 24, 2006, and June 6, 2007, an additional 100,000, 200,000 and 100,000 shares, respectively, of common stock became available for issuance under the PharmaNet Development Group, Inc. 2004 Employee Stock Purchase Plan, as amended and restated, in accordance with the provisions of the plan. As a result, this registration statement covers such additional 400,000 shares of common stock, for an aggregate of 550,000 shares of common stock registered under such plan.
(3)
Pursuant to Rule 416 of the Securities Act of 1933, as amended, this registration statement shall also cover any additional shares of common stock which become issuable under the PharmaNet Development Group, Inc. 2004 Employee Stock Purchase Plan, as amended and restated, by reason of any merger, consolidation, reorganization, recapitalization, reincorporation, stock dividend, dividend in property other than cash, stock split, liquidating dividend, combination of shares, exchange of shares, change in corporate structure or other transaction not involving the receipt of consideration by PharmaNet Development Group, Inc., which results in an increase in the number of the outstanding shares of common stock of PharmaNet Development Group, Inc.
(4)
Estimated solely for the purposes of calculating the registration fee pursuant to Rules 457(c) and 457(h) of the Securities Act of 1933, as amended, and based upon the average of the reported high and low sales prices per share of the common stock of PharmaNet Development Group, Inc., on April 3, 2008, as reported by the NASDAQ Global Select Market.
PART I - INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS
Item 1.
Plan Information
We will send or give the documents containing the information specified in Part I of Form S-8 to employees as specified by the Securities and Exchange Commission Rule 428(b)(1) under the Securities Act of 1933. We do not need to file these documents with the Securities and Exchange Commission either as part of this registration statement or as prospectuses or prospectus supplements under Rule 424 of the Securities Act.
Item 2.
Registrant Information and Employee Plan Annual Information
We will furnish without charge to each person to whom the prospectus is delivered, upon the oral or written request of such person, a copy of any and all of the documents incorporated by reference (other than exhibits to such documents). Requests should be directed to the attention of Ms. Anne-Marie Hess, PharmaNet Development Group, Inc., 504 Carnegie Center, Princeton, New Jersey 08540.
PART II - INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 3.
Incorporation of Documents by Reference
PharmaNet Development Group, Inc. (the "Registrant") hereby incorporates by reference into this Registration Statement the following documents previously filed with the Securities and Exchange Commission (the "Commission"):
(a)
The Registrant's Annual Report on Form 10-K for the fiscal year ended December 31, 2007 (Commission File No. 001-161119), filed on March 31, 2008, pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), in which there is set forth the audited financial statements for the Registrant's fiscal year ended December 31, 2007;
(b)
The Registrant's Current Report on Form 8-K filed on March 10, 2008;
(c)
The description of the Registrant's capital stock contained in its registration statement on Form 8-A filed with the SEC on December 28, 2005 to register Series A Junior Participating Preferred Stock Purchase Rights under the Exchange Act, including any amendments or reports filed for the purpose of updating such description; and
(d)
The description of the Registrant's capital stock contained in its registration statement on Form 8-A filed with the SEC on June 15, 2001 to register its common stock under the Exchange Act, including any amendments or reports filed for the purpose of updating such description.
All reports and definitive proxy or information statements filed pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act after the date of this Registration Statement and prior to the filing of a post-effective amendment which indicates that all securities offered hereby have been sold or which de-registers all securities then remaining unsold shall be deemed to be incorporated by reference into this Registration Statement and to be a part hereof from the date of filing of such documents. Unless expressly incorporated into this Registration Statement, a report furnished on Form 8-K under the Exchange Act shall not be incorporated by reference into this Registration Statement. Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any subsequently filed document which also is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.
Item 4.
Description of Securities.
Not Applicable.
Item 5.
Interests of Named Experts and Counsel.
Not Applicable.
Item 6.
Indemnification of Directors and Officers.
Our certificate of incorporation, as amended, provides that we shall indemnify our officers and directors, employees and agents and former officers, directors, employees and agents against expenses (including attorney's fees), judgments, fines and amounts paid in settlement arising out of his or her services on behalf of us subject to the qualifications contained in Delaware law as it now exists. We also cannot indemnify our officers and directors when we assert a direct claim against them. We have entered into indemnification agreements with our officers and directors providing for indemnification and containing an advancement of expenses provision. Delaware law generally provides that a corporation shall have such power to indemnify such persons to the extent they acted in good faith in a manner they reasonably believed to be in, or not opposed to, the best interests of the corporation and, with respect to any criminal action or proceeding, had no reasonable cause to believe the conduct was unlawful. In
II-1
the event any such person shall be judged liable, such indemnification shall apply only if approved by the court in which the action was brought. Any other indemnification shall be made by a majority vote of the board of directors (excluding any directors who were party to such action), or by a committee of directors designated by majority vote of the board of directors or by independent legal counsel in a written opinion, or by a majority vote of stockholders (excluding any stockholders who were parties to such action).
Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers or persons controlling PharmaNet Development Group, Inc., pursuant to the foregoing provisions, we have been informed that in the opinion of the Securities and Exchange Commission, such indemnification is against public policy as expressed in the Act and is therefore unenforceable.
Item 7.
Exemption from Registration Claimed.
Not Applicable.
Item 8.
Exhibits.
Exhibit Number
Item
5.1
Legal Opinion of Morgan, Lewis & Bockius LLP (filed herewith)
23.1
Consent of Grant Thornton, LLP (filed herewith)
23.2
Consent of Morgan, Lewis & Bockius LLP
(1)
(filed herewith)
24.1
Power of Attorney (included on signature page)
99.1
2004 Employee Stock Purchase Plan, as amended and restated
(2)
———————
(1)
Contained in the legal opinion.
(2)
Filed as an exhibit to the Company's annual report on Form 10-K which was filed on March 31, 2008.
Item 9.
Undertakings
A.
The undersigned Registrant hereby undertakes:
(i)
To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:
(a)
To include any prospectus required by Section 10(a)(3) of the Securities Act;
(b)
To reflect in the prospectus any facts or events arising after the effective date of this Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in this Registration Statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20 percent change in the maximum aggregate offering price set forth in the "Calculation of Registration Fee" table in the effective registration statement; and
(c)
To include any material information with respect to the plan of distribution not previously disclosed in this Registration Statement or any material change to such information in this Registration Statement;
provided, however,
that paragraphs (i) and (ii) of this section do not apply if the Registration Statement is on Form S-8 and the information required to be included in a post-effective
II-2
amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the Registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in this Registration Statement.
(ii)
That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial
bona fide
offering thereof.
(iii)
To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.
B.
The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Registrant's annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act that is incorporated by reference in this Registration Statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial
bona fide
offering thereof.
C.
Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.
II-3
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Princeton, State of New Jersey, on April 7, 2008.
PHARMANET DEVELOPMENT GROUP, INC.
By:
/s/ J
EFFREY
P. M
C
M
ULLEN
Jeffrey P. McMullen
Chief Executive Officer
POWER OF ATTORNEY
Each person whose signature appears below hereby constitutes and appoints each of Jeffrey P. McMullen and John P. Hamill, his true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution for him and in his name, place and stead, in any and all capacities, to sign any or all amendments or supplements to this registration statement, whether pre-effective or post-effective, and any registration statement relating hereto or thereto that is filed pursuant to Rule 462(b) under the Act, and to file the same with all exhibits thereto and other documents in connection therewith, with the SEC, granting unto said attorneys-in-fact and agents full power and authority to do and perform each and every act and thing necessary or appropriate to be done with respect to this registration statement or any amendments or supplements hereto in the premises, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or their substitute or substitutes, may lawfully do or cause to be done by virtue thereof.
Pursuant to the requirements of the Act, this registration statement has been signed below by the following persons in the capacities indicated.
/s/ P
ETER
G. T
OMBROS
Chairman of the Board of Directors
April 7, 2008
Peter G. Tombros
/s/ J
EFFREY
P. M
C
M
ULLEN
President and Chief Executive Officer and Director
(Principal Executive Officer)
April 7, 2008
Jeffrey P. McMullen
/s/ J
OHN
P. H
AMILL
Executive Vice President and Chief Financial Officer
(Principal Financial Officer and Principal Accounting Officer)
April 7, 2008
John P. Hamill
/s/ R
OLF
A. C
LASSON
Director
April 7, 2008
Rolf A. Classon
/s/ L
EWIS
R. E
LIAS
, MD
Director
April 7, 2008
Lewis R. Elias, MD
/s/ A
RNOLD
G
OLIEB
Director
April 7, 2008
Arnold Golieb
/s/ P
ER
W
OLD
-O
LSEN
Director
April 7, 2008
Per Wold-Olsen
/s/ D
AVID
M. O
LIVER
Director
April 7, 2008
David M. Oliver
II-4
EXHIBIT INDEX
Exhibit Number
Item
5.1
Legal Opinion of Morgan, Lewis & Bockius LLP (filed herewith)
23.1
Consent of Grant Thornton, LLP (filed herewith)
23.2
Consent of Morgan, Lewis & Bockius LLP
(1)
(filed herewith)
24.1
Power of Attorney (included on signature page)
99.1
2004 Employee Stock Purchase Plan, as amended and restated
(2)
———————
(1)
Contained in the legal opinion.
(2)
Filed as an exhibit to the Company's annual report on Form 10-K which was filed on March 31, 2008.